Neurotropic alphaviruses, which include western equine encephalitis virus (WEEV) and Fort Morgan virus, are mosquito-borne pathogens that infect the central nervous system causing acute and potentially fatal encephalitis. We previously reported a novel series of indole-2-carboxamides as alphavirus replication inhibitors, one of which conferred protection against neuroadapted Sindbis virus infection in mice. We describe here further development of this series, resulting in 10-fold improvement in potency in a WEEV replicon assay and up to 40-fold increases in half-lives in mouse liver microsomes. Using a rhodamine123 uptake assay in MDR1-MDCKII cells, we were able to identify structural modifications that markedly reduce recognition by P-glycoprotein, the key efflux transporter at the blood-brain barrier. In a preliminary mouse PK study, we were able to demonstrate that two new analogues could achieve higher and/or longer plasma drug exposures than our previous lead and that one compound achieved measurable drug levels in the brain.
Neurotropic alphaviruses, which include n class="Species">western equine encephalitis virus (WEEV) and Fort Morgan virus, are mosquito-borne pathogens that infect the central nervous system causing acute and potentially fatal encephalitis. We previously reported a novel series of indole-2-carboxamides as alphavirus replication inhibitors, one of which conferred protection against neuroadapted Sindbis virus infection in mice. We describe here further development of this series, resulting in 10-fold improvement in potency in a WEEV replicon assay and up to 40-fold increases in half-lives in mouse liver microsomes. Using a rhodamine123 uptake assay in MDR1-MDCKII cells, we were able to identify structural modifications that markedly reduce recognition by P-glycoprotein, the key efflux transporter at the blood-brain barrier. In a preliminary mouse PK study, we were able to demonstrate that two new analogues could achieve higher and/or longer plasma drug exposures than our previous lead and that one compound achieved measurable drug levels in the brain.
Authors: Michael S Bronze; Mark M Huycke; Linda J Machado; Gene W Voskuhl; Ronald A Greenfield Journal: Am J Med Sci Date: 2002-06 Impact factor: 2.378
Authors: Janice A Sindac; Bryan D Yestrepsky; Scott J Barraza; Kyle L Bolduc; Pennelope K Blakely; Richard F Keep; David N Irani; David J Miller; Scott D Larsen Journal: J Med Chem Date: 2012-04-03 Impact factor: 7.446
Authors: Scott D Larsen; Michael W Wilson; Akira Abe; Liming Shu; Christopher H George; Paul Kirchhoff; H D Hollis Showalter; Jianming Xiang; Richard F Keep; James A Shayman Journal: J Lipid Res Date: 2011-11-04 Impact factor: 5.922
Authors: Alan R Katritzky; Eric F V Scriven; Suman Majumder; Rena G Akhmedova; Anatoliy V Vakulenko; Novruz G Akhmedov; Ramiah Murugan; Khalil A Abboud Journal: Org Biomol Chem Date: 2005-01-10 Impact factor: 3.876
Authors: Jeewoo Lee; Sang-Uk Kang; Ju-Ok Lim; Hyun-Kyung Choi; Mi-kyung Jin; Attila Toth; Larry V Pearce; Richard Tran; Yun Wang; Tamas Szabo; Peter M Blumberg Journal: Bioorg Med Chem Date: 2004-01-15 Impact factor: 3.641
Authors: Jennifer M Frost; Michael J Dart; Karin R Tietje; Tiffany R Garrison; George K Grayson; Anthony V Daza; Odile F El-Kouhen; Betty B Yao; Gin C Hsieh; Madhavi Pai; Chang Z Zhu; Prasant Chandran; Michael D Meyer Journal: J Med Chem Date: 2010-01-14 Impact factor: 7.446
Authors: Scott J Barraza; Philip C Delekta; Janice A Sindac; Craig J Dobry; Jianming Xiang; Richard F Keep; David J Miller; Scott D Larsen Journal: Bioorg Med Chem Date: 2015-02-11 Impact factor: 3.641
Authors: Phillip C Delekta; Craig J Dobry; Janice A Sindac; Scott J Barraza; Pennelope K Blakely; Jianming Xiang; Paul D Kirchhoff; Richard F Keep; David N Irani; Scott D Larsen; David J Miller Journal: J Virol Date: 2014-07-16 Impact factor: 5.103
Authors: Yangfang Li; Qian Wu; Chen Li; Ling Liu; Kun Du; Jin Shen; Yuqin Wu; Xiaofen Zhao; Mei Zhao; Lingyun Bao; Jin Gao; Richard F Keep; Jianming Xiang Journal: PLoS One Date: 2016-06-14 Impact factor: 3.240
Authors: Xiaofen Zhao; Yangfang Li; Kun Du; Yuqin Wu; Ling Liu; Shan Cui; Yan Zhang; Jin Gao; Richard F Keep; Jianming Xiang Journal: PLoS One Date: 2019-11-27 Impact factor: 3.240
Authors: Xin Guo; Ayan Kumar Ghosh; Robert F Keyes; Francis Peterson; Michael Forman; David J Meyers; Ravit Arav-Boger Journal: Viruses Date: 2022-01-25 Impact factor: 5.048
Authors: Scott J Barraza; Janice A Sindac; Craig J Dobry; Philip C Delekta; Pil H Lee; David J Miller; Scott D Larsen Journal: Bioorg Med Chem Lett Date: 2021-06-15 Impact factor: 2.940